Results 271 to 280 of about 107,280 (285)
Some of the next articles are maybe not open access.
La Revue de medecine interne, 2005
Proteasome is involved in cell cycle and apoptosis regulation. Its deregulation could participate to oncogenesis.Bortezomib is the first proteasome inhibitor to reach clinical development. Its main adverse events are asthenia, thrombocytopenia and cumulative neurotoxicity which can limits long term use.
openaire +1 more source
Proteasome is involved in cell cycle and apoptosis regulation. Its deregulation could participate to oncogenesis.Bortezomib is the first proteasome inhibitor to reach clinical development. Its main adverse events are asthenia, thrombocytopenia and cumulative neurotoxicity which can limits long term use.
openaire +1 more source
2012
Proteasome inhibition is a rational approach to the therapy of multiple myeloma both alone and in combination with other agents, where proteasome inhibitors help induce chemosensitization and overcome drug resistance. These concepts were initially validated with laboratory-grade proteasome inhibitors and then with the clinically relevant peptide ...
openaire +1 more source
Proteasome inhibition is a rational approach to the therapy of multiple myeloma both alone and in combination with other agents, where proteasome inhibitors help induce chemosensitization and overcome drug resistance. These concepts were initially validated with laboratory-grade proteasome inhibitors and then with the clinically relevant peptide ...
openaire +1 more source
2004
The involvement of the 20S proteasome in the degradation of critical intracellular regulatory proteins has suggested the potential use of proteasome inhibitors as novel therapeutic agents being applicable in many different disease indications. Early synthetic inhibitors of the 20S proeteasome were relatively nonspecific compounds but proved to be ...
openaire +1 more source
The involvement of the 20S proteasome in the degradation of critical intracellular regulatory proteins has suggested the potential use of proteasome inhibitors as novel therapeutic agents being applicable in many different disease indications. Early synthetic inhibitors of the 20S proeteasome were relatively nonspecific compounds but proved to be ...
openaire +1 more source
Potent Inhibitors of Proteasome
Journal of Medicinal Chemistry, 1995M, Iqbal +7 more
openaire +2 more sources
[Proteasome and proteasome inhibitors].
Annales de dermatologie et de venereologie, 2006L, Meunier +5 more
openaire +1 more source
Proteasome Inhibitors: Introduction
Seminars in Hematology, 2012Christoph J. Heuck, John D. Shaughnessy
openaire +1 more source